From the Cosmetic Dermatology Archives

An Open-Label, Nonrandomized Pilot Study to Evaluate the Efficacy of a Bovine Caritlage&#150Based Wound-Dressing Powder for the Management of Deep and Subdermal Pediatric Burns

Author and Disclosure Information

Skin-grafting procedures are the treatment of choice for the management of deep second- and third degree burns. However, such procedures are highly invasive, require hospitalization, and are associated with a variety of risks, including infections, hematomas, anesthesia-related complications, and donor-site morbidity. Bovine cartilage–based preparations are well-established facilitators of wound healing, including burns. In this open-label, nonrandomized pilot study, a bovine cartilage–based wounddressing powder was applied to deep and subdermal second- and third-degree burns in 41 children who were unresponsive to conventional therapy with silver sulfadiazine and whose parents refused recommended skin grafting. Healing time averaged 34.8 days, which included the first 2 weeks of conventional treatment. In all cases, the wounds healed completely, with no residual scarring. No infections were detected after the start of treatment with the bovine cartilage–based wound-dressing powder and no adverse effects were reported. Our experience suggests that a bovine cartilage–based wound-dressing powder may be a viable option for the management of pediatric burns.


 

Recommended Reading

I've Got Needs!
MDedge Dermatology
ID Signature Nevi During Exam to Reduce Biopsies
MDedge Dermatology
Ipilimumab Side Effects Not Quelled by GI Drug
MDedge Dermatology
Nevi Do Not Develop Into Melanoma, Expert Suggests
MDedge Dermatology
Dysplastic Nevi May be Linked To Neonatal Jaundice Therapy
MDedge Dermatology
Prebiopsy Photos Help Prevent Wrong-Site Surgery
MDedge Dermatology
Nicks, Annotations Also Reduce Chance for Error During Mohs
MDedge Dermatology
Prophylactic Antibiotics Before Surgery Unnecessary in Most
MDedge Dermatology
Cetuximab Found to Yield Complete SCC Response
MDedge Dermatology
Skin Cancer Risks Tracked for Immunosuppressant Regimens
MDedge Dermatology